Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | MPI | P34949 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29590472 | 0.97 | ALDH1A1 (0.38) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL31553148 | 0.89 | ALDH1A1 (0.44) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL1944013 | 0.85 | ACHE (0.54) | ALDH1A1KDM4EMAPTGAALMNA | |
| SCHEMBL8173238 | 0.82 | CYP3A4 (0.44) | ALDH1A1MAPTGAAACHETDP1 | |
| SCHEMBL28361493 | 0.81 | PTPN1 (0.36) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL5440663 | 0.81 | RAPGEF4 (0.38) | RAPGEF4ALDH1A1KDM4EMAPTGAA | |
| SCHEMBL30739444 | 0.81 | ACHE (0.48) | ALDH1A1KDM4EMAPTGAALMNA | |
| SCHEMBL29157546 | 0.81 | ACHE (0.48) | ALDH1A1KDM4EMAPTGAALMNA | |
| SCHEMBL31629060 | 0.80 | PTGS1 (0.33) | CA1 | |
| SCHEMBL28114604 | 0.80 | ALDH1A1 (0.32) | RAPGEF4ALDH1A1KDM4EMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119824421-A | Molybdenum etching solution | 湖北兴福电子材料股份有限公司 | 2025-04-15 | — | — | CN | claimed |
| CN-115928264-B | Preparation method of continuous silicon carbide fiber containing metal in near-stoichiometric ratio | 湖南泽睿新材料有限公司 | 2024-02-20 | — | — | CN | claimed |
| CN-105358611-B | The method for manufacturing non-roasting type electrode | E.I.内穆尔杜邦公司 | 2018-07-17 | — | — | CN | claimed |
| CN-119824421-A | Molybdenum etching solution | 湖北兴福电子材料股份有限公司 | 2025-04-15 | — | — | CN | disclosed |
| CN-118156608-A | Lithium ion secondary battery | 泰星能源解决方案有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-116199721-A | Organic phosphorescence luminescent material and luminescent device | 北京云基科技股份有限公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-110520731-B | Kit, method and reagent for measuring substance to be measured | 富士胶片株式会社 | 2023-04-28 | — | — | CN | disclosed |
| CN-110546507-B | Kit and method for measuring substance to be measured in living body sample | 富士胶片株式会社 | 2023-04-21 | — | — | CN | disclosed |
| CN-112592363-B | Fused ring compound containing boron atoms and selenium/tellurium atoms and organic electroluminescent device | 中国科学院长春应用化学研究所 | 2022-12-20 | — | — | CN | disclosed |
| CN-115322229-A | Organic electrophosphorescent luminescent material and application thereof | 北京云基科技有限公司 | 2022-11-11 | — | — | CN | disclosed |
| US-11434420-B2 | Color conversion composition, compound used for same, and light emitting device | FUJIFILM CORPORATION (JP) | 2022-09-06 | — | — | US | disclosed |
| CN-104540871-B | The preparation method of aromatic compound | 住友化学株式会社 | 2016-08-24 | — | — | CN | disclosed |
| CN-105358611-A | Method of manufacturing non-fired type electrode | DU PONT | 2016-02-24 | — | — | CN | disclosed |
| CN-104684959-A | Process for producing aromatic compound | SUMITOMO CHEMICAL CO | 2015-06-03 | — | — | CN | disclosed |
| CN-104540871-A | Method for producing aromatic compound | SUMITOMO CHEMICAL CO | 2015-04-22 | — | — | CN | disclosed |
| US-7410925-B2 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-08-12 | — | — | US | disclosed |
| US-7008897-B2 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-07 | — | — | US | disclosed |
| US-20060030480-A1 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2006-02-09 | — | — | US | disclosed |
| US-20040209763-A1 | Metal compound, and catalyst component and catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-10-21 | — | — | US | disclosed |
| CN-1217725-A | polymerizable composition | CIBA GEIGY AG (CH) | 1999-05-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11434420-B2 | Color conversion composition, compound used for same, and light emitting device | CRY1, CRY2, CYBA | RAPGEF4 3799/4885ALDH1A1 346/4885KDM4E 3234/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.